IMUC spiking on 3X avg vol ahead of presentation this afternoon. Could make a nice break >1.43, it's hod
ImmunoCellular Therapeutics' Chief Executive Officer to Present at Prestigious Cancer Stem Cell Conference
10:18 am ET 12/08/2010- Business Wire
LOS ANGELES--(BUSINESS WIRE)--Dec. 8, 2010-- ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a biotechnology company focused on the development of novel immune-based cancer therapies, announced today that Manish Singh Ph.D., the company's President and Chief Executive Officer, will present at the World Cancer Stem Cell Summit at the Boston Park Plaza Hotel & Towers in Boston, MA. on Thursday, December 9th at 2:05 p.m.
The World CSC Summit focuses on overcoming the challenges faced in utilizing cancer stem cell therapies, exploring the very latest lines of research and the move into clinical trials. The event features innovative case studies and cutting-edge practical insights, bringing together thought leaders from all areas involved in cancer stem cell study. For more information about the World Cancer Stem Cell Conference, please visit www.csc-summit.com.
